Document is current
Any future updates will be listed below
-
Authors
Taha, Zaid https://orcid.org/0000-0002-2660-0560
Crupi, Mathieu Joseph François https://orcid.org/0000-0002-4452-2383
Alluqmani, Nouf
MacKenzie, Duncan
Vallati, Sydney
Whelan, Jack Timothy
Fareez, Faiha
Alwithenani, Akram
Petryk, Julia
Chen, Andrew
Spinelli, Marcus Mathew
Ng, Kristy
Sobh, Judy
de Souza, Christiano Tanese
Bharadwa, Priya Rose
Lee, Timothy Kit Hin
Thomas, Dylan Anthony
Huang, Ben Zhen
Kassas, Omar
Poutou, Joanna
Gilchrist, Victoria Heather
Boulton, Stephen https://orcid.org/0000-0002-2521-2240
Thomson, Max
Marius, Ricardo
Hooshyar, Mohsen
McComb, Scott
Arulanandam, Rozanne https://orcid.org/0000-0002-4750-499X
Ilkow, Carolina Solange
Bell, John Cameron https://orcid.org/0000-0002-9083-357X
Diallo, Jean-Simon https://orcid.org/0000-0002-4862-2795
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (705952, 377104, 377104)
Terry Fox Research Institute (TFF-122868)
Mitacs
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
Canadian Cancer Society Research Institute (708044, 706162, 706162)
- License Information
-
More Information
Article History
Received: 12 October 2023
Accepted: 9 August 2024
First Online: 23 August 2024
Competing interests
: Z.T., M.J.F.C, J.C.B., J-S.D. report having a pending patent directly related to this work entitled “Delivery vehicles expressing engineered antigens and uses thereof” (U.S. Provisional Patent Application No. 63/680, 672). The other authors declare no competing interests.
